世界のワクチンアジュバント市場予測2021年-2026年

【英語タイトル】Vaccine Adjuvants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

IMARCが出版した調査資料(IMA22FB416)・商品コード:IMA22FB416
・発行会社(調査会社):IMARC
・発行日:2021年12月10日
・ページ数:145
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD2,299 ⇒換算¥340,252見積依頼/購入/質問フォーム
Five UserUSD3,399 ⇒換算¥503,052見積依頼/購入/質問フォーム
EnterprisewideUSD
Warning: Undefined variable $YEN_price3 in /home/hibp2/marketreport.jp/public_html/wp-content/themes/twentyfourteen/content.php on line 355
0 ⇒換算¥
見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

本調査レポートでは、世界のワクチンアジュバント市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、製品種類別(アジュバントエマルジョン、病原体成分、粒子状アジュバント、混合アジュバント、その他)分析、投与経路別(経口、筋肉内、鼻腔内、皮下、皮内、その他)分析、疾患別(癌、感染症、その他)分析、用途別(研究、商業)分析、地域別分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目を掲載しています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション
・世界のワクチンアジュバント市場規模:製品種類別(アジュバントエマルジョン、病原体成分、粒子状アジュバント、混合アジュバント、その他)
・世界のワクチンアジュバント市場規模:投与経路別(経口、筋肉内、鼻腔内、皮下、皮内、その他)
・世界のワクチンアジュバント市場規模:疾患別(癌、感染症、その他)
・世界のワクチンアジュバント市場規模:用途別(研究、商業)
・世界のワクチンアジュバント市場規模:地域別
・SWOT分析
・バリューチェーン分析
・ファイブフォース分析
・価格指標
・競争状況

The global vaccine adjuvants market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 12% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Vaccines contain weakened and dead germs that initiate the immune response and activate antigen presenting cells (APCs). This reaction helps the body increase its ability to induce long-term protection and safety against any infection. Vaccine adjuvants are compounds that improve this immunogenic reaction of the body against antigens that have insufficient immunostimulatory capabilities. Aluminum salts and MF59, an oil-in-water emulsion composed of squalene, are among the two common adjuvants that are feasible for human use.

Vaccine Adjuvants Market Trends:
The global vaccine adjuvants market is primarily driven by the rising prevalence of allergies and infectious diseases, including cancer, human immunodeficiency virus (HIV/AIDS), human papillomavirus (HPV) and tuberculosis. The need for advanced treatment options for existing and emerging fatal diseases has resulted in the development of vaccines that have long-lasting effects on immunization. For instance, key manufacturers have developed new adjuvants such as AS01, ISCOM & ISCOMMATRIX, and AS02, which are under clinical trials. Besides this, governments of various countries are taking initiatives for immunization and advancements in adjuvants for human use. They are also focusing on improving healthcare infrastructure and increasing investments for research and development (R&D) of new therapeutics. For example, market players are investing in the development of novel vaccine adjuvants as a potential solution against diseases caused by challenging pathogens, such as malaria and herpes, as well as for vulnerable populations that respond poorly to traditional vaccines, including older adults, neonates, and individuals with compromised immunity and comorbidities. Moreover, with the spread of the coronavirus disease (COVID-19) pandemic caused by SARS-CoV-2, there has been an increasing demand for effective and safe vaccine adjuvants. These factors are expected to provide a positive outlook for the market in the upcoming years.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global vaccine adjuvants market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product type, route of administration, diseases and application.

Breakup by Product Type:
Adjuvant Emulsions
Pathogen Components
Particulate Adjuvants
Combination Adjuvants
Others

Breakup by Route of Administration:
Oral
Intramuscular
Intranasal
Subcutaneous
Intradermal
Others

Breakup by Diseases:
Cancer
Infectious Diseases
Others

Breakup by Application:
Research
Commercial

Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Adjuvance Tecchnologies Inc., Adjuvatis, Agenus Inc., Brenntag SE, Chemtrade Logistics Inc., CSL Limited, Croda International Plc, Invivogen, Novavax Inc., OZ Biosciences and Virometix AG.

Key Questions Answered in This Report:
How has the global vaccine adjuvants market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global vaccine adjuvants market?
What are the key regional markets?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the diseases?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global vaccine adjuvants market and who are the key players?
What is the degree of competition in the industry?

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Vaccine Adjuvants Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product Type
6.1 Adjuvant Emulsions
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Pathogen Components
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Particulate Adjuvants
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Combination Adjuvants
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Route of Administration
7.1 Oral
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Intramuscular
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Intranasal
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Subcutaneous
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Intradermal
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Diseases
8.1 Cancer
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Infectious Diseases
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Application
9.1 Research
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Commercial
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Adjuvance Tecchnologies Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Adjuvatis
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Agenus Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Brenntag SE
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.5 Chemtrade Logistics Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 CSL Limited
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Croda International Plc
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Invivogen
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Novavax Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 OZ Biosciences
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Virometix AG
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio

Figure 1: Global: Vaccine Adjuvants Market: Major Drivers and Challenges
Figure 2: Global: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015-2020
Figure 3: Global: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 4: Global: Vaccine Adjuvants Market: Breakup by Product Type (in %), 2020
Figure 5: Global: Vaccine Adjuvants Market: Breakup by Route of Administration (in %), 2020
Figure 6: Global: Vaccine Adjuvants Market: Breakup by Diseases (in %), 2020
Figure 7: Global: Vaccine Adjuvants Market: Breakup by Application (in %), 2020
Figure 8: Global: Vaccine Adjuvants Market: Breakup by Region (in %), 2020
Figure 9: Global: Vaccine Adjuvants (Adjuvant Emulsions) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Vaccine Adjuvants (Adjuvant Emulsions) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Vaccine Adjuvants (Pathogen Components) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Vaccine Adjuvants (Pathogen Components) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Vaccine Adjuvants (Particulate Adjuvants) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Vaccine Adjuvants (Particulate Adjuvants) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Vaccine Adjuvants (Combination Adjuvants) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Vaccine Adjuvants (Combination Adjuvants) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Vaccine Adjuvants (Other Product Types) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Vaccine Adjuvants (Other Product Types) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Vaccine Adjuvants (Oral) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Vaccine Adjuvants (Oral) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Vaccine Adjuvants (Intramuscular) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Vaccine Adjuvants (Intramuscular) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Vaccine Adjuvants (Intranasal) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Vaccine Adjuvants (Intranasal) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Vaccine Adjuvants (Subcutaneous) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Global: Vaccine Adjuvants (Subcutaneous) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Vaccine Adjuvants (Intradermal) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Global: Vaccine Adjuvants (Intradermal) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Global: Vaccine Adjuvants (Other Routes of Administration) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Global: Vaccine Adjuvants (Other Routes of Administration) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Global: Vaccine Adjuvants (Cancer) Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Global: Vaccine Adjuvants (Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Global: Vaccine Adjuvants (Infectious Diseases) Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Global: Vaccine Adjuvants (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Global: Vaccine Adjuvants (Other Diseases) Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Global: Vaccine Adjuvants (Other Diseases) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Global: Vaccine Adjuvants (Research) Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Global: Vaccine Adjuvants (Research) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Global: Vaccine Adjuvants (Commercial) Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Global: Vaccine Adjuvants (Commercial) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: North America: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: North America: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: United States: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: United States: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: Canada: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: Canada: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: Asia-Pacific: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: Asia-Pacific: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: China: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: China: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: Japan: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: Japan: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: India: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: India: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: South Korea: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: South Korea: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: Australia: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: Australia: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: Indonesia: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: Indonesia: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Others: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Others: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: Europe: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: Europe: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: Germany: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: Germany: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: France: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: France: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: United Kingdom: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: United Kingdom: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: Italy: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 72: Italy: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Spain: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: Spain: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Russia: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 76: Russia: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 77: Others: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 78: Others: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 79: Latin America: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 80: Latin America: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 81: Brazil: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 82: Brazil: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 83: Mexico: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 84: Mexico: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 85: Others: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 86: Others: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 87: Middle East and Africa: Vaccine Adjuvants Market: Sales Value (in Million US$), 2015 & 2020
Figure 88: Middle East and Africa: Vaccine Adjuvants Market: Breakup by Country (in %), 2020
Figure 89: Middle East and Africa: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 90: Global: Vaccine Adjuvants Industry: SWOT Analysis
Figure 91: Global: Vaccine Adjuvants Industry: Value Chain Analysis
Figure 92: Global: Vaccine Adjuvants Industry: Porter's Five Forces Analysis

Table 1: Global: Vaccine Adjuvants Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Vaccine Adjuvants Market Forecast: Breakup by Product Type (in Million US$), 2021-2026
Table 3: Global: Vaccine Adjuvants Market Forecast: Breakup by Route of Administration (in Million US$), 2021-2026
Table 4: Global: Vaccine Adjuvants Market Forecast: Breakup by Diseases (in Million US$), 2021-2026
Table 5: Global: Vaccine Adjuvants Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 6: Global: Vaccine Adjuvants Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 7: Global: Vaccine Adjuvants Market: Competitive Structure
Table 8: Global: Vaccine Adjuvants Market: Key Players

★調査レポート[世界のワクチンアジュバント市場予測2021年-2026年] (コード:IMA22FB416)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のワクチンアジュバント市場予測2021年-2026年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆